The Report Card

Your carotid artery scan is compared to our proprietary database of over 40,000 patients of which over 1,000,000 data points have been mapped and categorized by age, gender and ethnic background. Plaque formation, the development of lesions and arterial blockage will be accurately identified in its earliest stages of disease development. A cardiovascular health assessment report card is generated that reflects your state of heart health and grades your risk from low to high. All other scores are relative to your medical history and require a consultation with your physician.

Category A

Normal risk for your Age & Gender
Very low probability of cardiovascular disease (CVD) – It is important to maintain your actual health status. Control your way of life (diet, exercise, etc.). We suggest you to check up the risk factors (cholesterol, diabetes, etc) in order to maintain this health status. We recommend another HeartSmartIMTplus® in 24 months.

Category B

Slightly above Normal risk for your Age & Gender
Low probability of CVD – Ask your physician for changes in your way of live (diet, exercises, etc.) and for checking up the risk factors- We recommend a new HeartSmartIMTplus study in 18 to 24 months.

Category C

It is possible to have a significant disease. Ask your physician for changing your way of live (diet, exercises, etc.) and for checking up the risk factors. We recommend a new HeartSmartIMTplus study once a year for evaluating the effectiveness of the changes.
Up to 2 x Normal risk for your Age & Gender

Category D

High probability of CVD – Ask your physician immediately- We recommend a new HeartSmartIMTplus study at your Physician’s request twice a year to evaluate the effectiveness of the treatment.
Up to 2 x Normal risk for your Age & Gender

Category E

Very high probability of CVD – Ask your physician immediately for a complete cardiovascular check up, for changes in the live-style and for medical treatment.- We recommend a new HeartSmartIMTplus study at your Physician’s request twice a year to evaluate the effectiveness of the treatment.
Above 2 x up to 2.7x normal risk for your age and gender